A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 22,750 shares of ENTA stock, worth $247,292. This represents 3.54% of its overall portfolio holdings.

Number of Shares
22,750
Previous 22,750 -0.0%
Holding current value
$247,292
Previous $1.08 Million 9.77%
% of portfolio
3.54%
Previous 2.71%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$56.06 - $74.11 $1.28 Million - $1.69 Million
22,750 New
22,750 $1.62 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $225M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Foresite Capital Opportunity Management V, LLC Portfolio

Follow Foresite Capital Opportunity Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.